17 June 2019
Visiongain has launched a new pharma report Global Ophthalmic Drugs Market Forecast 2019-2029: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs.
The market for ophthalmic drugs is relatively fragmented with a large number of drugs competing for market shares. We note that there are many drugs within the various sectors of the market that have lost exclusivity in the major markets and have therefore been subjected to generic drug competition. Despite generic penetration, the global market for ophthalmic drugs is a growing one with a hive of activities and multiple products in various stages of development.
The lead analyst of the report commented "The market for ophthalmic drugs is a growing one. Although it is currently dominated by a handful of companies, the market still provides opportunities for companies looking to introduce innovative solutions to meet the chronic needs within the market.
Blockbuster drugs are becoming increasingly few within the market as drugs become more targeted. We note that future growth within ophthalmic drugs will likely be driven by innovation from smaller players, possibly in partnership with one of the major companies in the market. The increased demand for drugs and the efforts going into R&D will benefit these smaller players and help to stimulate their growth over the forecast period. With many targeting eye diseases and conditions where significant unmet treatment needs exist, rapid uptake of these products can be expected."
Leading companies featured in the report include Allergan (Actavis), Bayer, Novartis, Pfizer, Regeneron, Roche, Santen, Senju, Valeant and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
27 September 2023
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
25 September 2023
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
21 September 2023
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.